StockNews.AI
LUCD
StockNews.AI
84 days

Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes

1. Lucid Diagnostics will join the Russell 2000® and 3000® indices on June 27, 2025. 2. This move may attract institutional investors and enhance stock liquidity.

2m saved
Insight
Article

FAQ

Why Bullish?

Membership in the Russell indices generally leads to increased investor interest and potential price appreciation. Historical examples show stocks joining such indices experience positive price movement as institutional buying increases.

How important is it?

Joining major indices significantly enhances visibility and liquidity for LUCD, making it more attractive to a wider range of investors.

Why Short Term?

The impact is expected to be short-term, coinciding with the reconstitution date when investors react to the inclusion.

Related Companies

PAVM
NEW YORK , May 27, 2025 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that the Company will join the small-cap Russell 2000® Index and the broad-market Russell 3000® Index, effective after the close of U.S. equity markets on June 27, 2025, as part of their 2025 annual reconstitution, according to a preliminary list of additions posted by FTSE Russell on May 23, 2025. "We are pleased that Lucid is joining these important market indices, which serve as leading benchmarks for institutional investors and as the basis for numerous index-linked financial products," said Dennis McGrath , Lucid's Chief Financial Officer.

Related News